Phytochemical analysis and anti-infective potential of fungal endophytes isolated from Nigella sativa seeds.


Journal

BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981

Informations de publication

Date de publication:
16 11 2023
Historique:
received: 03 04 2023
accepted: 23 10 2023
medline: 20 11 2023
pubmed: 17 11 2023
entrez: 17 11 2023
Statut: epublish

Résumé

Endophytic fungi, particularly from higher plants have proven to be a rich source of antimicrobial secondary metabolites. The purpose of this study is to examine the antimicrobial potential of three endophytic fungi Aspergillus sp. SA1, Aspergillus sp. SA2, and Aspergillus sp. SA3, cultivated from Nigella sativa seeds against Staphylococcus aureus (ATCC 9144), Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), Klebsiella pneumoniae (ATCC 13883), MRSA (ATCC 33591), and human pathogen Candida albicans (ATCC 10231). Furthermore, the most active cultivated endophytic fungi were molecularly identified via internal transcribed spacer (ITS) sequencing. HR-ESIMS guided approach has been used successfully in chemical profiling of 26 known bioactive secondary metabolites (1-26), which belongs to different classes of natural compounds such as polyketides, benzenoids, quinones, alcohols, phenols or alkaloids. Finally, in-silico interactions within active site of fungal Cyp51 and bacterial DNA gyrase revealed possibility of being a hit-target for such metabolites as antimicrobials.

Identifiants

pubmed: 37974074
doi: 10.1186/s12866-023-03085-4
pii: 10.1186/s12866-023-03085-4
pmc: PMC10652552
doi:

Substances chimiques

Anti-Infective Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

343

Informations de copyright

© 2023. The Author(s).

Références

Prog Chem Org Nat Prod. 2017;104:127-246
pubmed: 28160212
Mar Drugs. 2012 Oct;10(10):2208-2221
pubmed: 23170078
Can J Microbiol. 2009 Dec;55(12):1381-91
pubmed: 20029530
Mar Drugs. 2010 Dec 27;9(1):59-70
pubmed: 21339945
Metabolites. 2022 Jan 17;12(1):
pubmed: 35050207
Folia Microbiol (Praha). 2020 Apr;65(2):293-302
pubmed: 31273645
J Nat Prod. 2008 Dec;71(12):2064-7
pubmed: 19053517
J Gerontol A Biol Sci Med Sci. 2006 Mar;61(3):262-6
pubmed: 16567375
J Nat Prod. 2000 Jul;63(7):975-7
pubmed: 10924177
Front Microbiol. 2016 Mar 01;7:219
pubmed: 26973605
Afr J Tradit Complement Altern Med. 2011;8(2):159-64
pubmed: 22238497
Nat Protoc. 2008;3(2):163-75
pubmed: 18274517
J Mol Evol. 1980 Dec;16(2):111-20
pubmed: 7463489
Nat Prod Res. 2023 Aug-Sep;37(17):2905-2910
pubmed: 36305731
Int J Mol Sci. 2021 Feb 13;22(4):
pubmed: 33668523
Plant Physiol Biochem. 2018 Jan;122:1-9
pubmed: 29169080
Inflamm Regen. 2023 Feb 28;43(1):17
pubmed: 36849892
J Nat Prod. 2012 Apr 27;75(4):812-33
pubmed: 22502590
Nat Rev Microbiol. 2005 Dec;3(12):937-47
pubmed: 16322742
J Microbiol Biotechnol. 2009 Dec;19(12):1573-5
pubmed: 20075621
Appl Microbiol Biotechnol. 1999 Oct;52(4):455-63
pubmed: 10570792
J Nat Prod. 2001 Jan;64(1):125-6
pubmed: 11170686
Sci Pharm. 2011;79(4):937-50
pubmed: 22145116
Antimicrob Agents Chemother. 1986 Jul;30(1):147-51
pubmed: 3019234
Mar Drugs. 2014 Dec 09;12(12):5902-15
pubmed: 25501793
Med Mycol. 2009;47(6):601-8
pubmed: 18798050
J Agric Food Chem. 2019 Oct 30;67(43):11994-12001
pubmed: 31618578
Molecules. 2018 Aug 09;23(8):
pubmed: 30096887
Pharmacogn Rev. 2013 Jan;7(13):11-6
pubmed: 23922451
Toxins (Basel). 2020 Nov 12;12(11):
pubmed: 33198270
Mar Genomics. 2015 Dec;24 Pt 1:21-30
pubmed: 26204808
Phytochemistry. 2020 Jul;175:112374
pubmed: 32315839
J Antibiot (Tokyo). 1996 Jan;49(1):31-6
pubmed: 8609082
Biotechnol Lett. 2015 Jul;37(7):1325-34
pubmed: 25792513
J Am Chem Soc. 2012 Mar 14;134(10):4709-20
pubmed: 22329759
Nat Prod Res. 2014;28(24):2334-7
pubmed: 25022791
J Agric Food Chem. 2016 Sep 7;64(35):6659-71
pubmed: 27538469
Curr Opin Microbiol. 2006 Jun;9(3):240-4
pubmed: 16647289
Pharmazie. 2006 Dec;61(12):1041-4
pubmed: 17283665
FEMS Microbiol Ecol. 2016 Aug;92(8):
pubmed: 27222223
Biomolecules. 2020 May 15;10(5):
pubmed: 32429259
Biochem Pharmacol. 2004 Aug 1;68(3):549-61
pubmed: 15242821
J Nat Prod. 2020 Jan 24;83(1):99-104
pubmed: 31867967
Int J Syst Evol Microbiol. 2013 Sep;63(Pt 9):3487-3493
pubmed: 23543503
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Sci Rep. 2021 Feb 2;11(1):2770
pubmed: 33531542
Antioxidants (Basel). 2022 Sep 01;11(9):
pubmed: 36139817
Nat Prod Res. 2022 May;36(9):2404-2408
pubmed: 33043694
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417
Can J Microbiol. 2001 Sep;47(9):829-41
pubmed: 11683465
Folia Microbiol (Praha). 2006;51(4):273-7
pubmed: 17007423
J Antibiot (Tokyo). 2005 Jun;58(6):416-9
pubmed: 16156520

Auteurs

Nourhan Hisham Shady (NH)

Department of Pharmacognosy, Faculty of Pharmacy, Deraya University, New Minia City, Minia, Egypt. Norhan.shady@deraya.edu.eg.

Sara Khalid Sobhy (SK)

Department of Botany and Microbiology, Faculty of Science, Minia University, Minia, 61519, Egypt.
Faculty of Pharmacy, Deraya University, New Minia City, Minia, Egypt.

Yaser A Mostafa (YA)

Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt.
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Badr University in Assiut, Assiut, 77771, Egypt.

Ramadan Yahia (R)

Department of Microbiology and immunology, Faculty of Pharmacy, Deraya University, New Minia City, Minia, Egypt.

Stefanie P Glaeser (SP)

Institute of Applied Microbiology, Justus-Liebig University Gießen, Gießen, Germany.

Peter Kämpfer (P)

Institute of Applied Microbiology, Justus-Liebig University Gießen, Gießen, Germany.

Mo'men H El-Katatny (MH)

Department of Botany and Microbiology, Faculty of Science, Minia University, Minia, 61519, Egypt.

Usama Ramadan Abdelmohsen (UR)

Department of Pharmacognosy, Faculty of Pharmacy, Deraya University, New Minia City, Minia, Egypt. usama.ramadan@mu.edu.eg.
Department of Pharmacognosy, faculty of pharmacy, Minia university, Minia, Egypt. usama.ramadan@mu.edu.eg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH